Compass Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 08/14/2026 | 17.99 M | $39.40 M | 7.15% | 9.63% |
| ORBIMED ADVISORS LLC | 08/14/2026 | 15.22 M | $33.33 M | 0.00% | 8.15% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 08/14/2026 | 14.10 M | $30.88 M | -1.44% | 7.55% |
| BLACKROCK, INC. | 08/07/2026 | 11.28 M | $24.71 M | 18.68% | 6.04% |
| STATE STREET CORP | 09/22/2026 | 9.95 M | $21.80 M | 48.67% | 5.33% |
| ENAVATE SCIENCES GP, LLC | 08/14/2026 | 7.79 M | $17.06 M | 0.00% | 4.17% |
| VIVO CAPITAL, LLC | 08/14/2026 | 7.76 M | $16.99 M | -18.74% | 4.15% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 6.12 M | $13.40 M | 1.35% | 3.28% |
| PALO ALTO INVESTORS LP | 08/19/2026 | 5.83 M | $12.77 M | 285.06% | 3.12% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 4.71 M | $10.32 M | 456.98% | 2.52% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 3.82 M | $8.36 M | 6.99% | 2.04% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 3.77 M | $8.26 M | 248.31% | 2.02% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 3.69 M | $8.08 M | 44.59% | 1.97% |
| BLUE OWL CAPITAL HOLDINGS LP | 08/11/2026 | 3.62 M | $7.94 M | 23.20% | 1.94% |
| CITADEL ADVISORS LLC | 09/02/2026 | 3.57 M | $7.82 M | 394.96% | 1.91% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 3.53 M | $7.73 M | 76.96% | 1.89% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2026 | 3.52 M | $7.72 M | 6.64% | 1.89% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 3.51 M | $7.69 M | 1,650.82% | 1.88% |
| BIRCHVIEW CAPITAL, LP | 08/14/2026 | 1.68 M | $3.67 M | 14.27% | 0.90% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 08/14/2026 | 1.40 M | $3.07 M | 100.00% | 0.75% |
| FISHER ASSET MANAGEMENT, LLC | 08/04/2026 | 1.39 M | $3.05 M | 3.24% | 0.75% |
| ROYCE & ASSOCIATES LP | 08/14/2026 | 1.34 M | $2.93 M | -17.47% | 0.72% |
| FMR LLC | 08/13/2026 | 1.21 M | $2.65 M | -32.72% | 0.65% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2026 | 1.19 M | $2.60 M | -86.02% | 0.64% |
| ACADIAN ASSET MANAGEMENT LLC | 08/13/2026 | 1.16 M | $2.54 M | 100.00% | 0.62% |
| NORTHERN TRUST CORP | 08/13/2026 | 1.14 M | $2.50 M | 8.81% | 0.61% |
| HEALTHINVEST PARTNERS AB | 07/24/2026 | 1.05 M | $2.30 M | 2,406.74% | 0.56% |
| NUVEEN, LLC | 08/11/2026 | 1.01 M | $2.21 M | 247.31% | 0.54% |
| SQUAREPOINT OPS LLC | 08/14/2026 | 1.01 M | $2.21 M | 1,906.91% | 0.54% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 1.00 M | $2.19 M | 0.28% | 0.54% |
| BLACKSTONE INC. | 08/14/2026 | 899.94 K | $1.97 M | -51.56% | 0.48% |
| FIRST TRUST ADVISORS LP | 08/11/2026 | 807.00 K | $1.77 M | 100.00% | 0.43% |
| JPMORGAN CHASE & CO | 08/12/2026 | 789.40 K | $1.71 M | -6.88% | 0.42% |
| KVP CAPITAL ADVISORS, LP | 08/13/2026 | 771.00 K | $1.69 M | 54.20% | 0.41% |
| MORGAN STANLEY | 08/13/2026 | 735.19 K | $1.61 M | 104.01% | 0.39% |
| CITIGROUP INC | 08/03/2026 | 713.91 K | $1.56 M | 19.33% | 0.38% |
| UBS GROUP AG | 08/13/2026 | 712.76 K | $1.56 M | -70.19% | 0.38% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 08/14/2026 | 700.00 K | $1.53 M | 0.00% | 0.37% |
| POINT72 ASSET MANAGEMENT, L.P. | 08/14/2026 | 686.58 K | $1.50 M | 100.00% | 0.37% |
| ACUTA CAPITAL PARTNERS, LLC | 08/14/2026 | 595.21 K | $1.30 M | -29.90% | 0.32% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 566.92 K | $1.24 M | -34.51% | 0.30% |
| CM MANAGEMENT, LLC | 08/13/2026 | 550.00 K | $1.20 M | 100.00% | 0.29% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 541.18 K | $1.18 M | 23.06% | 0.29% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 08/13/2026 | 523.78 K | $1.15 M | 5.21% | 0.28% |
| ARTIA GLOBAL PARTNERS LP | 08/14/2026 | 383.20 K | $839.21 K | 100.00% | 0.21% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 378.69 K | $829.32 K | 5.15% | 0.20% |
| ARROWMARK COLORADO HOLDINGS LLC | 08/13/2026 | 364.74 K | $798.79 K | -29.15% | 0.20% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 351.03 K | $768.76 K | 18.07% | 0.19% |
| MARSHALL WACE, LLP | 08/13/2026 | 334.87 K | $733.36 K | 100.00% | 0.18% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 320.31 K | $701.48 K | 867.71% | 0.17% |
Compass Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 277 institutional investors and hedge funds held shares of Compass Therapeutics Inc. The most heavily invested institutionals were:
Wealth Enhancement Trust Services, Inc.: 0
TANG CAPITAL MANAGEMENT LLC: 17.99 M
ORBIMED ADVISORS LLC: 15.22 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 14.1 M
BlackRock, Inc.: 11.28 M
STATE STREET CORP: 9.95 M
88.87% of Compass Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 185.46 M shares in the last 24 months. This purchase volume represents approximately $1.01 B in transactions.